Katayama Pharmaceutical Co., Ltd.

Started to synthesize fine organic and inorganic reagents

1922: Founded in Osaka City: Started synthesis business of organic and inorganic reagents

Incorporation in November, Showa 25 (1950)

1953: Started synthesis of chemicals for photographic paper: (Color couplers, related chemicals, and sensitizing dyes, etc.)

(Color couplers, related additives and sensitizing dyes etc.)

1969: Hirakata Factory completed

Hirakata plant (Hirakata city, Osaka)

1980: Expanded into pharmaceutical-related business

1988: Toyama Factory first manufacturing building completed, began production of active pharmaceutical ingredients

Started to manufacture API of medicine

1989: Began production of active pharmaceutical ingredients for new drugs

1993: Toyama Factory second manufacturing building completed

1995: Started contract manufacturing of clinical trial active pharmaceutical ingredients and intermediates

2004: FDA GMP inspection at Toyama Factory

2007: AIFA/EMA GMP inspection at Toyama Factory

2008: FDA GMP inspection at Hirakata Factory

2011: PMDA GMP inspection at Toyama Factory

2012: Became a consolidated subsidiary of Sakai Chemical Industry Co., Ltd.: PMDA GMP inspection at Toyama Factory

Toyama plant PMDA GMP inspection

2013: PMDA GMP inspection at Toyama Factory

2014: FDA GMP inspection at Hirakata Factory

2015: PMDA GMP inspection at Toyama Factory

2016 : Toyama Factory Building 3 Completion : Toyama Factory FDA GMP Inspection

Toyama plant FDA GMP inspection

2017 : Hirakata Factory FDA GMP Inspection

2018 : Hirakata Factory PMDA GMP Inspection

2019 : Toyama Factory FDA GMP Inspection

2021 : Toyama Factory PMDA GMP Inspection

2022 : Hirakata Factory FDA GMP Inspection

2024 : New Headquarters Building Completion